Redeye returns with an updated take on the Q3 report. We are encouraged by the UK approval of Sedaconda but believe our previous sales estimates were too optimistic. Hence, we reconsider our financial estimates for the coming years.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Sedana Medical Q3 - Accelerated geographical expansion up next

© Modular Finance, source Nordic Press Releases